ArticleBlood cancer journal2014

The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma.

A Tagde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.